Affiliation:
1. National Medical Research Center for Therapy and Preventive Medicine
Abstract
Polycythemia vera is not only a clonal disease that causes hematopoietic stem cells, but also a pathology that often leads to thrombotic complications. Thrombosis can have different localization and is clinically manifested by stroke, myocardial infarction, deep vein thrombosis of the lower extremities, pulmonary embolism, thrombosis of the veins of internal organs and other conditions. One of the most formidable thrombotic complications is acute cerebrovascular accident. The heterogeneity of the possible causes of acute cerebrovascular accident requires a careful approach to differential diagnosis for timely diagnosis and individual, pathogenetically grounded selection of means of long-term antithrombotic therapy. The presented clinical case of the development of cerebrovascular accident in a patient with polycythemia vera demonstrates the importance of an informal approach to diagnosis, as well as interdisciplinary interaction for finding the true cause of the development of acute cerebrovascular accident and the appointment of pathogenetically based treatment, aimed, among other things, at the prevention of repeated episodes of acute cerebrovascular accident and others. thrombotic complications.
Publisher
Stolichnaya Izdatelskaya Kompaniyaizdat
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine
Reference7 articles.
1. Melikyan AL, Kovrigina AM, Subortseva IN, et al. National clinical guidelines for diagnosis and therapy of Ph-negative myeloproliferative neoplasms (polycythemia vera, essential thrombocythemia, primary myelofibrosis) (edition 2018). Russian Journal of Hematology and Transfusiology. 2018;63(3):275-315 (In Russ.) DOI: 10.25837/HAT.2019.51.88.001.
2. Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol. 2017;92(1):94-108. DOI:10.1002/ajh.24607.
3. Abdulkadyrov KM, Shuvaev VA, Martynkevich IS. Myeloproliferative neoplasms. St. Petersburg, Moscow: Literra; 2016 (In Russ)
4. Phipps MS, Cronin CA. Management of acute ischemic stroke. BMJ. 2020;368:l6983. DOI:10.1136/bmj.l6983.
5. Roitman EV, Shabalina AA, Tanashyan MM. Formalised assessment of systemic thrombo-genicity in patients with Polycythemia vera suffered an ischemic stroke. Atherothrombosis. 2020;(2):105-14 (In Russ.) DOI:10.21518/2307-1109-2020-2-105-114.